These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1090 related items for PubMed ID: 11040850
1. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Blute ML, Amling CL, Bryant SC, Zincke H. Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850 [Abstract] [Full Text] [Related]
2. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H. J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342 [Abstract] [Full Text] [Related]
5. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, Benoit G. Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091 [Abstract] [Full Text] [Related]
6. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M. Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334 [Abstract] [Full Text] [Related]
7. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H. J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276 [Abstract] [Full Text] [Related]
8. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project. Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [Abstract] [Full Text] [Related]
9. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML. J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287 [Abstract] [Full Text] [Related]
10. Outcomes following partial nephrectomy by tumor size. Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC. J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543 [Abstract] [Full Text] [Related]
11. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C, Song C, Hong JH, Kim CS, Ahn H. J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [Abstract] [Full Text] [Related]
12. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424 [Abstract] [Full Text] [Related]
13. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [Abstract] [Full Text] [Related]
14. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma. Suzuki K, Mizuno R, Mikami S, Tanaka N, Kanao K, Kikuchi E, Miyajima A, Nakagawa K, Oya M. Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408 [Abstract] [Full Text] [Related]
15. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718 [Abstract] [Full Text] [Related]
16. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma. Bölükbas S, Kudelin N, Eberlein M, Fisseler-Eckhoff A, Schirren J. Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364 [Abstract] [Full Text] [Related]